checkAd

     335  0 Kommentare Gerresheimer reports strong first quarter - Seite 2


    same time, Gerresheimer made further investments in expanding the
    Peachtree City, USA, plant for the production of asthma inhalers and
    other medical plastic systems. In addition, work continued on
    standardizing and modernizing machinery for the manufacture of
    injection vials and cartridges worldwide.

    Outlook

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Gerresheimer AG!
    Long
    95,20€
    Basispreis
    0,76
    Ask
    × 13,75
    Hebel
    Short
    108,88€
    Basispreis
    0,79
    Ask
    × 12,73
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Gerresheimer's expectations for financial year 2016 continue to be
    set out in the following, in each case based on constant exchange
    rates. For the US dollar-which will account for about a third of
    Group revenues in 2016 going forward and is likely to have the
    largest currency impact on the Group currency-Gerresheimer continues
    to assume an exchange rate of approximately USD 1.12 to EUR 1.00.

    In financial year 2016, the Company continues to anticipate Group
    revenues of around EUR 1.5bn (plus or minus EUR 25m) on a constant
    exchange rate basis. The Group revenues of around EUR 1.5bn
    correspond to revenue growth of some 9% at constant exchange rates
    compared with revenues in financial year 2015, and organic revenue
    growth of between 4% and 5%. Adjusted EBITDA is expected to increase
    to some EUR 320m (plus or minus EUR 10m) in financial year 2016.
    Capital expenditure in financial year 2016 is forecast to account for
    around 8% of revenues at constant exchange rates.

    In addition, the Company confirmed its guidance for the financial
    years 2016 to 2018, in each case stated at constant exchange rates
    and assuming a US dollar exchange rate of USD 1.12 to EUR 1.00.
    Gerresheimer is aiming for average annual organic revenue growth of
    between 4% and 5% for the period from 2016 to 2018. For the adjusted
    EBITDA margin, the Group has set a target of around 22% for financial
    year 2018. In order to meet these targets, Gerresheimer will in all
    probability require significantly lower annual capital expenditure of
    the order of only about 8% of revenues at constant exchange rates.

    The full quarterly report is available here:
    www.gerresheimer.com/en/investor-relations/reports

    Originaltext: Gerresheimer AG
    digital press kits: http://www.presseportal.de/nr/9072
    press kits via RSS: http://www.presseportal.de/rss/pm_9072.rss2
    ISIN: DE000A0LD6E6

    Contact:
    Jens Kürten
    Group Senior Director Communication & Marketing
    Phone +49 211 6181-250
    Telefax +49 211 6181-241
    E-Mail j.kuerten@gerresheimer.com
    Internet www.gerresheimer.com
    Seite 2 von 2


    Diskutieren Sie über die enthaltenen Werte


    news aktuell
    0 Follower
    Autor folgen

    Verfasst von news aktuell
    Gerresheimer reports strong first quarter - Seite 2 - Crioss reference: Full press release is available at http://www.presseportal.de/dokumente - - First quarter revenues up 13.4% to EUR 342.3m - Adjusted EBITDA grows by 29.6% to EUR 66.0m (Q1 2015: EUR 51.0m) - Adjusted earnings per …

    Schreibe Deinen Kommentar

    Disclaimer